Target intelligence / Profile preview

Negatively charged viral envelopes and capsids

Molecular classification
Viral structural component, Lipid assembly, Protein assembly
01

Overview

Negatively charged viral envelopes and capsids are fundamental structural components that facilitate the survival and infectivity of various viruses. The anionic nature of these surfaces often stems from the presence of phosphatidylserine in the lipid envelope or acidic residues within the capsid protein assembly (Soares et al., 2008, Nature Medicine). These components are essential for protecting the viral genome and mediating host cell attachment and entry (Zasloff, 2002, Nature). Therapeutic strategies targeting these surfaces typically employ cationic molecules, such as antimicrobial peptides or synthetic dendrimers like astodrimer sodium, which bind via electrostatic attraction (McCarthy et al., 2005, Molecular Pharmaceutics). This binding can lead to the physical disruption of the viral envelope or the competitive inhibition of viral attachment to host receptors. Because this target is based on conserved physical properties, it provides a pathway for broad-spectrum antiviral development against pathogens like HIV, HSV, and Influenza (Telwatte et al., 2011, Antiviral Research). However, a primary challenge remains the potential for off-target effects on host cell membranes, necessitating high selectivity in drug design.

Other names
Anionic viral surfacesViral envelopeViral capsidViral lipid bilayerAnionic viral envelope
02

Mechanism of action

Electrostatic binding to anionic viral surfaces leading to membrane disruption or inhibition of host cell attachment.

03

Biological functions

Viral entryGenome protectionHost cell attachmentMembrane fusion
04

Disease associations

Infection
05

Safety considerations

Off-target effects on host cell membranesHemolysisSystemic toxicity
06

Interacting drugs

Astodrimer sodium

4 more in the full profile.

07

Biomarkers

Viral loadPhosphatidylserine exposure

Beyond the preview

Go deeper on Negatively charged viral envelopes and capsids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Negatively charged viral envelopes and capsids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call